Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/15/2846799/0/en/Vivoryon-Therapeutics-N-V-Announces-Changes-to-Board-Composition.html
https://www.fiercebiotech.com/biotech/vivoryon-profoundly-disappointed-alzheimers-drug-phase-2-fail-stock-crashes
https://www.globenewswire.com//news-release/2024/01/08/2805035/0/en/Vivoryon-Therapeutics-N-V-to-Host-Investor-Meetings-in-January-2024.html
https://www.globenewswire.com//news-release/2023/11/28/2786596/0/en/Vivoryon-Therapeutics-N-V-to-Report-Q3-2023-Financial-Results-and-Operational-Progress-on-December-6-2023.html
https://www.globenewswire.com//news-release/2023/11/07/2774649/0/en/Vivoryon-Therapeutics-N-V-to-Present-at-Upcoming-Investor-Conference.html
https://www.globenewswire.com//news-release/2023/10/26/2767091/0/en/Vivoryon-Therapeutics-N-V-Provides-Comprehensive-Progress-Report-for-Ongoing-Varoglutamstat-Clinical-Program-Following-R-D-Event-and-VIVA-MIND-DSMB-Dose-Decision.html
https://www.globenewswire.com//news-release/2023/10/23/2764370/0/en/Vivoryon-Therapeutics-N-V-Reports-Positive-Outcome-from-Independent-Data-Safety-Monitoring-Board-with-Unanimous-Decision-for-VIVA-MIND-U-S-Study-of-Varoglutamstat-in-Alzheimer-s-Di.html
https://www.globenewswire.com//news-release/2023/10/17/2761639/0/en/Vivoryon-Therapeutics-N-V-Shares-Highlights-from-Virtual-R-D-Event-with-Key-Opinion-Leaders.html
https://www.globenewswire.com//news-release/2023/10/05/2755049/0/en/Vivoryon-Therapeutics-N-V-Announces-Virtual-R-D-Event-with-Key-Opinion-Leaders-and-Upcoming-Conference-Participation.html
https://www.globenewswire.com//news-release/2023/09/15/2743929/0/en/Vivoryon-Therapeutics-N-V-Extraordinary-General-Meeting-Approved-Appointment-of-New-Executive-Directors-to-the-Board.html